Meteora launches three major product upgrades, plans TGE on October 23
Foresight News reported that Solana ecosystem liquidity protocol Meteora has announced three major product upgrades aimed at transforming the way tokens are issued, including Presale Vaults, Meteora Invent, and Dynamic Fee Sharing. Presale Vaults allow projects to raise funds on their own terms before launch, ensuring strong support for tokens prior to issuance. Meteora Invent streamlines the issuance process, enabling teams to quickly launch complex offerings with simple commands, thus lowering the technical barrier. The Dynamic Fee Sharing technology enables the design of unique fee distribution models for token issuance, allowing project teams to flexibly choose how fees are allocated, ensuring fairness and flexibility. Meteora stated that during the upcoming Token Generation Event (TGE) on Thursday (October 23), it will fully leverage its technology to support the issuance of the MET token.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Uniswap.com Domain Story Resurfaces After SBF Purchase Claim
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
